Data Quality Assurance Clause Samples

Data Quality Assurance. In order to ensure the data quality standards, Pro Public will reasonably meet the five standards of data quality as mentioned in USAID (ADS 203) framework. i) Validity ii) Integrity iii) Precision iv) Reliability v) Timeliness Data quality will be ensured by cross-checking the data receive from the field visits. Project staff will make their presence on major activities and facilitate capacity building in reporting to DFs. In addition, project team make realizes the importance of data quality to DFs and local coordinators

Data Quality Assurance. ‌ All patient data relating to the study will be recorded on printed or electronic CRF unless transmitted to the Sponsor or designee electronically (eg, laboratory data). The Investigator is responsible for verifying that data entries are accurate and correct by physically or electronically signing the CRF. The Investigator must maintain accurate documentation (source data) that supports the information entered in the CRF. The Investigator must permit study-related monitoring, audits, IRB/IEC review, and regulatory agency inspections and provide direct access to source data documents. Monitoring details describing strategy, methods, responsibilities and requirements, including handling of noncompliance issues and monitoring techniques (central, remote, or on-site monitoring) are provided in the Medical Monitoring, Safety Monitoring and Global Monitoring Plans. The Sponsor or designee is responsible for the data management of this study including quality checking of the data. The Sponsor assumes accountability for actions delegated to other individuals (eg, Contract Research Organizations [CRO]). Study monitors will perform ongoing source data verification to confirm that data entered into the CRF by authorized site personnel are accurate, complete, and verifiable from source documents; that the safety and rights of patients are being protected; and that the study is being conducted in accordance with the currently approved protocol and any other study agreements, ICH GCP, and all applicable regulatory requirements. Records and documents, including signed ICFs, pertaining to the conduct of this study must be retained by the Investigator for 2 years after the last marketing application approval, or if not approved, 2 years following the discontinuance of the study medication, unless local regulations or institutional policies require a longer retention period. No records may be destroyed during the retention period without the written approval of the Sponsor. No records may be transferred to another location or party without written notification to the Sponsor.

Data Quality Assurance. 9.1 The Parties collate data on waste collection and record that information through DEFRA's data recording system known as “Waste Data Flow”. The Parties agree to adopt the Audit Commission‟s code of practice on data quality standards as set out in Schedule 6, Part C (The Standards for Better Quality Data, A Voluntary Code of Practice) in order to ensure the accuracy, validity, reliability, timeliness, relevance, completeness and security of information. 9.2 The Parties agree to apply the data quality standards within each partner organisation, ensuring that there is periodic reinforcement of the value placed on data quality. 9.3 The Parties agree to adopt a policy with regard to data quality of „getting it right first time‟ with a view to avoiding waste in the form of time and money spent on cleansing data. The Parties aspiration with regard to data quality is to be 100% accurate 100% of the time. 9.4 The Parties agree to continue to take the preparation and reporting of performance information seriously and demonstrate commitment to improve data quality.

Data Quality Assurance. 7.1 Information shared under the agreement will be adequate to help with the effective discharge of MAPPA purposes. It will be relevant and not contain excessive detail beyond that which is required for the defined purpose(s). 7.2 Information discovered to be inaccurate, out-of-date or inadequate for the purpose should be notified to the originating owner of the data – who will be responsible for correcting the data and notifying all other recipients of the information who must make sure the correction is made. 7.3 If an agency wishes to disclose shared information to a third party, as best practice the agency should seek written consent from the agency that provided the information. If a statutory requirement for disclosure exists then consent for further disclosure is not required. Any agency must ensure that all principles of the Data Protection Act are adhered to. Therefore, if an agency makes a further disclosure to a third party they must ensure that the sharing of personal data is not processed in any manner incompatible with the purpose/s it was obtained for. 7.4 As best practise all information shared is only valid at the time of provision, and should only be used for the purpose as requested. However, the recipient organisation becomes the Data Controller for the shared information therefore the information may be used for subsequent investigations, if it is being used for a purpose that is compatible with the purpose for which it was obtained, i.e. prevention and detection of crime and disorder.

Data Quality Assurance. ‌ Several quality assurance measures were implemented to ensure that data were of high quality. In addition to the training described above, supervisors and E2A/Pathfinder staff monitored the fieldwork to ensure completeness of data and to ensure adherence to assessment guidelines. A data quality consultant also collected data independently in randomly selected facilities. This data was not significantly different from those collected by the research assistants. Field teams also met daily to review their work, discuss problems and challenges, explore ways to improve data-collection activities, and plan for the following day.

Data Quality Assurance. All subject data relating to the study will be recorded on printed or electronic CRFs unless transmitted to the Sponsor or designee electronically (eg, laboratory data). The investigator is responsible for verifying that data entries are accurate and correct by physically or electronically signing the CRF. The investigator must maintain attributable, legible, contemporaneous, original, and accurate documentation (source data) that supports the information entered in the CRF. The investigator must permit study-related monitoring, audits, IRB/IEC review, and regulatory agency inspections and provide direct access to source data documents. Details describing monitoring strategy (eg, risk-based initiatives in operations and quality such as risk management and mitigation strategies and analytical risk-based monitoring), methods, responsibilities and requirements, including handling of noncompliance issues and monitoring techniques (central, remote, or on-site monitoring) are provided in the Monitoring Plan. The Sponsor or designee is responsible for the data management of this study including quality review of the data. The Sponsor maintains ultimate responsibility for the quality and integrity of study data, even if study-related duties and functions are transferred to other individuals or organizations (eg, contractors or contract research organizations). Study monitors will perform ongoing source data verification to confirm that data entered into the CRF by authorized site personnel are attributable, legible, contemporaneous, original, and accurate from source documents; that the safety and rights of subjects are being protected; and that the study is being conducted in accordance with the currently approved protocol and any other study agreements, ICH GCP, and applicable regulatory requirements. Records and documents, including signed ICFs, pertaining to the conduct of this study must be retained by the investigator per ICH GCP and local regulations or institutional policies. No records may be destroyed during the retention period without the written approval of the Sponsor. No records may be transferred to another location or party without written notification to the Sponsor.

Data Quality Assurance. The project will not only utilize a variety of data collection tools, but in doing so, the project will employ data quality assurance procedures/mechanism to help us decide if the data is valid, attributable, truthful, precise, reliable, and timely.

Data Quality Assurance. All participant data relating to the study will be recorded on printed or electronic CRF unless transmitted to Alexion or designee electronically (eg, laboratory data). The Investigator is responsible for verifying that data entries are accurate and correct by physically or electronically signing the CRF. • The Investigator must maintain accurate documentation (source data) that supports the information entered in the CRF. • The Investigator must permit study-related monitoring, audits, IRB/IEC review, and regulatory agency inspections and provide direct access to source data documents. • Alexion or designee is responsible for the data management of this study including quality checking of the data. • Study monitors will perform ongoing source data verification to confirm that data entered into the CRF by authorized site personnel are accurate, complete, and verifiable from source documents; that the safety and rights of participants are being protected; and that the study is being conducted in accordance with the currently approved protocol and any other study agreements, ICH GCP, and all applicable regulatory requirements. • Records and documents, including signed ICFs, pertaining to the conduct of this study must be retained by the Investigator for a minimum of 25 years after study completion, unless local regulations or institutional policies require a longer retention period. No records may be destroyed during the retention period without the written approval of ▇▇▇▇▇▇▇. No records may be transferred to another location or party without written notification to ▇▇▇▇▇▇▇.

Data Quality Assurance. ● All participant data relating to the study will be recorded on printed or electronic CRF unless transmitted to the sponsor or designee electronically (e.g. laboratory data). The Investigator (or designee) is responsible for verifying that data entries are accurate and correct by physically or electronically signing the CRF. ● The investigator must maintain accurate documentation (source data). ● The investigator must permit study-related monitoring, audits, IRB review, and regulatory agency inspections and provide direct access to source data. ● Monitoring details describing strategy (e.g. risk-based initiatives in operations and quality such as Risk Management and Mitigation Strategies and Analytical Risk-Based Monitoring), methods, responsibilities and requirements, including handling of noncompliance issues and monitoring techniques (central, remote, or on-site monitoring) are provided in the Monitoring Plan. ● The sponsor or designee is responsible for the data management of this study including quality checking of the data.